Back to mobile site

Galmed Pharma (GLMD) Misses Q3 EPS by 25c

November 12, 2014 7:20 AM EST

Galmed Pharma (NASDAQ: GLMD) reported Q3 EPS of ($0.62), $0.25 worse than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings